Details for Patent: 6,299,900
Summary for Patent: 6,299,900
| Title: | Dermal penetration enhancers and drug delivery systems involving same |
| Abstract: | A transdermal drug delivery system which comprises at least one physiologically active agent or prodrug thereof and at least one dermal penetration enhancer; characterized in that the dermal penetration enhancer is a safe skin-tolerant ester sunscreen. A non-occlusive, percutaneous or transdermal drug delivery system which comprises: (i) an effective amount of at least one physiologically active agent or prodrug thereof; (ii) at least one non-volatile dermal penetration enhancer; and (iii) at least one volatile liquid; characterised in that the dermal penetration enhancer is adapted to transport the physiologically active agent across a dermal surface or mucosal membrane of an animal, including a human, when the volatile liquid evaporates, to form a reservoir or depot of a mixture comprising the penetration enhancer and the physiologically active agent or prodrug within said surface or membrane; and the dermal penetration enhancer is of low toxicity to, and is tolerated by, the dermal surface or mucosal membrane of the animal. |
| Inventor(s): | Barry Leonard Reed, Timothy Matthias Morgan, Barrie Charles Finnin |
| Assignee: | Acrux DDS Pty Ltd |
| Application Number: | US09/125,436 |
|
Patent Claim Types: see list of patent claims | Use; Delivery; Device; |
Drugs Protected by US Patent 6,299,900
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 6,299,900
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Australia | PN 8144 | Feb 19, 1996 |
| PCT Information | |||
| PCT Filed | February 19, 1997 | PCT Application Number: | PCT/AU97/00091 |
| PCT Publication Date: | August 21, 1997 | PCT Publication Number: | WO97/29735 |
International Family Members for US Patent 6,299,900
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 0901368 | ⤷ Start Trial | C300523 | Netherlands | ⤷ Start Trial |
| European Patent Office | 0901368 | ⤷ Start Trial | CA 2012 00010 | Denmark | ⤷ Start Trial |
| European Patent Office | 0901368 | ⤷ Start Trial | 91973 | Luxembourg | ⤷ Start Trial |
| European Patent Office | 1769785 | ⤷ Start Trial | C300522 | Netherlands | ⤷ Start Trial |
| European Patent Office | 1769785 | ⤷ Start Trial | C300521 | Netherlands | ⤷ Start Trial |
| European Patent Office | 1769785 | ⤷ Start Trial | CA 2012 00011 | Denmark | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
